MedTech & Diagnostics
SkinHealth Systems Executive Compensation (FY25)
SKIN · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025 ◇ Pedro Malha | Latest say-on-pay support = June 10, 2026 | Chief executive pay ratio ◇ To the median employee |
Velarion Member: every covered company in MedTech & Diagnostics, with dashboards, peer screens and board-ready briefs. Three seats, one year.
The paid brief on SkinHealth Systems
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Data as of October 25, 2026Latest filing (DEF 14A): August 12, 2026
9 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Velarion Intel, one year, every company
221 figures on this page: 216 cited to the filing that reported them, 5 calculated from figures it prints. See the citations
More on SkinHealth Systems
Five data products on this company. Each one is requested through the developer setup page.
- Peer Disclosure Audit$5The comparison companies this board named, each one tied to the filing that lists it.How to get Peer Disclosure Audit
- Governance Provisions PullfreeThe governance provisions as the proxy states them: board leadership, committee membership, and shareholder rights.How to get Governance Provisions Pull
- Say-on-Pay Risk Signal$9A risk band for the next say-on-pay vote, with the support history and the peer comparison behind it.How to get Say-on-Pay Risk Signal
- NEO Comp Report$24Every named executive officer’s pay by element and year, with the citation behind each figure.How to get NEO Comp Report
- Board Comp Report$24What each non-employee director was paid, the standing fee schedule, and the equity each one holds at year end.How to get Board Comp Report
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive of record: Marla Beck → Pedro Malha
Say-on-pay support: 77.5% → 82.6% (5.1 points higher)
CEO pay ratio: 82:1 → 72:1 (12.2% lower)
Frequently asked questions
Answers drawn from the data on this page.
Who is SkinHealth Systems' chief executive and what were they paid?
Pedro Malha was paid $6,311,321 in total compensation as President, Chief Executive Officer, and Director for fiscal 2025.
What was SkinHealth Systems' say-on-pay result?
Shareholders supported the say-on-pay proposal with 82.6% of votes cast for or against in favor at the meeting held June 10, 2026 for fiscal 2025.
Which companies are in SkinHealth Systems' peer group?
The disclosed peer group names Beauty, Inc., Hims & Hers Health, Inspire Medical Systems, Interparfums, Inc. and Olaplex Holdings Inc, among others.
What is SkinHealth Systems' chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 72:1, against median employee compensation of $105,574.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Andrew Stanleick Former Chief Executive Officer and President | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Daniel Watson Chief Revenue Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Liyuan Woo Former Chief Financial Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Andrew Stanleick Former Chief Executive Officer and President Departed during or after this year | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Brad Hauser Former Chief Operating Officer | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Liyuan Woo Former Chief Financial Officer Departed during or after this year | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Michael Monahan Chief Financial Officer | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Daniel Watson Chief Revenue Officer | ◇ | — | ◇ | — | ◇ | ◇ | ◇ | ◇ |
Marla Beck Chief Executive Officer and Former Interim Chief Executive Officer Served on an interim basis | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Marla Beck Chief Executive Officer and Former Interim Chief Executive Officer | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Daniel Watson Chief Revenue Officer | ◇ | ◇ | ◇ | — | ◇ | ◇ | ◇ | ◇ |
Michael Monahan Chief Financial Officer | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Brad Hauser Former Chief Operating Officer Departed during or after this year | ◇ | ◇ | — | — | — | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Marla Beck Former President, Chief Executive Officer and Director Departed during or after this year | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Pedro Malha President, Chief Executive Officer, and Director | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Michael Monahan Chief Financial Officer | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Sheri Lewis Chief Operations, Quality and Technology Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Ron Menezes Chief Revenue Officer | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Marla Beck | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Marla Beck | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Michael Monahan | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Michael Monahan | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Pedro Malha | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Pedro Malha | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Pedro Malha | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Pedro Malha | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Ron Menezes | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Ron Menezes | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Sheri Lewis | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Sheri Lewis | RSU | ◇ | — | — | ◇ | — | — | ◇ |
Fiscal 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Pedro Malha | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Ron Menezes | RSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| Michael Monahan | RSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Sheri Lewis | RSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Doug Schillinger | ◇ | ◇ | — | — | — | — | ◇ |
Brenton L. Saunders Board chair | ◇ | ◇ | — | — | — | — | ◇ |
Michelle Kerrick | ◇ | ◇ | — | — | — | — | ◇ |
Stephen J. Fanning | ◇ | ◇ | — | — | — | — | ◇ |
Brian Miller | ◇ | ◇ | — | — | — | — | ◇ |
Desiree Gruber | ◇ | ◇ | — | — | — | — | ◇ |
Philippe Schaison, PharmaD | ◇ | ◇ | — | — | — | — | ◇ |
E. Scott Beattie, Kenneth Tripp, Sachin Shridharani, M.D and Pedro Malha served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Board chair premium | ◇ |
| Audit committee chair | ◇ |
| Audit committee member | ◇ |
| Compensation committee chair | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance chair | ◇ |
| Nominating and governance member | ◇ |
Equity is delivered as restricted stock units.
Stock ownership guideline: 5x cash retainer
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- Beauty, Inc. SBH
- Hims & Hers Health HIMS
- Inspire Medical Systems INSP
- Interparfums, Inc. IPAR
- Olaplex Holdings Inc OLPX
- Sight Sciences Inc SGHT
- Tactile Systems Tech TCMD
- USANA Health Sciences USNA
- YETI Holdings, Inc. YETI
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | June 10, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | June 12, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | June 6, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | June 14, 2023 | = | ◇ | ◇ | ◇ |
| 2021 | June 28, 2022 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Ask our research desk — $99, 24h, every figure cited to its filing.
Sample answer — “What is the CEO’s total compensation?”
- Pedro Malha (President, Chief Executive Officer, and Director), FY2025 total compensation $6,311,321 (base salary $163,077) [exec_comp, SEC accession 0001683168-26-003189, filed 2026-04-24]What this page does not include
Everything above is a fact SkinHealth Systems disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where SkinHealth Systems sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
221 figures on this page: 216 cited to the filing that reported them, 5 calculated from figures it prints.
216 cited to the filing
5 calculated from the filing
Documents cited
- 0001683168-26-006273DIRECTOR COMPENSATION &
- 0001628280-26-043539
- 0001683168-26-0031892025 DIRECTOR COMPENSATION · CEO Pay Ratio · Grants of Plan-Based Awards in Fiscal 2025 · Outstanding Equity Awards at Fiscal Year-End Table · and 1 more section
- 0001628280-25-031820
- 0001683168-25-002840Summary Compensation Table
- 0001628280-24-027695Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001683168-24-002718Summary Compensation Table
- 0001628280-23-022890
- 0001818093-22-000110
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “SkinHealth Systems executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/SKIN (accessed 2026).
Short form: data: Velarion
The paid brief for SkinHealth Systems
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
9 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about SkinHealth Systems and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
MedTech & Diagnostics rankings
Peers SkinHealth Systems discloses
The companies named in SKIN's own disclosed peer group.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}